Sergio Vázquez, María José Villanueva, José Luis Fírvida, Begoña Campos, Martín Lázaro, Gerardo Huidobro, María del Carmen Areses, Natalia Fernández, Marta Covela, and Joaquín Casal. 2015. “Erlotinib As Second-Line Therapy for Patients With Advanced Non-Small-Cell Lung Cancer and Wild-Type EGFR Tumors”. Journal of Analytical Oncology 4 (3): 94-101. https://doi.org/10.6000/1927-7229.2015.04.03.1.